197 related articles for article (PubMed ID: 2950215)
1. General anesthesia in a malignant hyperthermia susceptible patient.
Jones JE; Dierdorf SF; Clapp DW
J Oral Med; 1987; 42(1):22-4, 66. PubMed ID: 2950215
[No Abstract] [Full Text] [Related]
2. Effective use of dantrolene in a patient susceptible to malignant hyperthermia.
Gallagher DM; Hyer RL
J Oral Surg; 1980 Jun; 38(6):438-40. PubMed ID: 6929328
[No Abstract] [Full Text] [Related]
3. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
[TBL] [Abstract][Full Text] [Related]
4. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
[TBL] [Abstract][Full Text] [Related]
5. Malignant hyperthermia susceptibility--successful management with a "stressfree" technique.
Jantzen JP; Erdmann K; Kleemann PP
Acta Anaesthesiol Belg; 1987; 38(1):107-13. PubMed ID: 3591264
[TBL] [Abstract][Full Text] [Related]
6. A protocol to manage malignant hyperthermia with general anesthesia.
Roberts MW
Pediatr Dent; 1993; 15(1):45-6. PubMed ID: 7901841
[No Abstract] [Full Text] [Related]
7. [Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
Shindoh M; Enomoto K; Tatekawa S; Yukioka H; Yoshimoto N; Fujimori M
Masui; 1988 Jul; 37(7):861-7. PubMed ID: 3230633
[No Abstract] [Full Text] [Related]
8. [Anaesthesia in a patient susceptible to malignant hyperthermia (author's transl)].
Schuh FT; Maier C
Anaesthesist; 1982 May; 31(5):245-7. PubMed ID: 7103032
[TBL] [Abstract][Full Text] [Related]
9. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
Harrison GG
Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
[TBL] [Abstract][Full Text] [Related]
10. Treatment of a patient susceptible to malignant hyperthermia.
Warrington RD; Kochansky CY; Bach DE
Clin Prev Dent; 1986; 8(1):27-9. PubMed ID: 2937600
[No Abstract] [Full Text] [Related]
11. Malignant hyperthermia after oral and intravenous pretreatment with dantrolene in a patient susceptible to malignant hyperthermia.
Ruhland G; Hinkle AJ
Anesthesiology; 1984 Feb; 60(2):159-60. PubMed ID: 6696240
[No Abstract] [Full Text] [Related]
12. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
Schulte-Sasse U; Eberlein HJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
[TBL] [Abstract][Full Text] [Related]
13. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
Free CW; Jaimon MP
N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient].
Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K
Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231
[No Abstract] [Full Text] [Related]
15. Malignant hyperthermia in a patient receiving nitrous oxide.
Waite PD; Ballard JB; Yonfa A
J Oral Maxillofac Surg; 1985 Nov; 43(11):907-9. PubMed ID: 3863903
[TBL] [Abstract][Full Text] [Related]
16. [A case of malignant hyperthermia; successful treatment with intravenous dantrolene sodium].
Noda B; Higa K; Naitoh H; Dan K
Masui; 1985 Jun; 34(6):822-7. PubMed ID: 4032707
[No Abstract] [Full Text] [Related]
17. Propofol for anesthesia in a patient susceptible to malignant hyperthermia.
Rosenberg MB
Anesth Prog; 1991; 38(3):96-8. PubMed ID: 1839946
[TBL] [Abstract][Full Text] [Related]
18. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
[TBL] [Abstract][Full Text] [Related]
19. [2 cases of intra-anesthetic malignant hyperthermia with fatal outcome. Is prevention possible?].
Castot A; Simons J; De Gialluly E; Muzard O; Lagier G; Efthymiou ML; Fournier E
Therapie; 1984; 39(3):311-7. PubMed ID: 6463956
[No Abstract] [Full Text] [Related]
20. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
Watson CB; Reierson N; Norfleet EA
Anesthesiology; 1986 Sep; 65(3):312-4. PubMed ID: 3752576
[No Abstract] [Full Text] [Related]
[Next] [New Search]
